TrialPapillomavirus research (Amsterdam, Netherlands)2019

Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort study.

Partha Basu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.